Scientific article
English

Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study

Published inClinical Infectious Diseases, vol. 64, no. 9, p. 1275-1278
Publication date2017
Abstract

We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.

Keywords
  • Adult
  • Anti-HIV Agents/therapeutic use
  • Cohort Studies
  • Female
  • HIV Infections/complications/drug therapy
  • Hepatitis B virus/isolation & purification
  • Hepatitis B
  • Chronic/complications/virology
  • Hepatitis D/virology
  • Hepatitis Delta Virus/drug effects/isolation & purification/physiology
  • Humans
  • Male
  • Middle Aged
  • Switzerland
  • Tenofovir/therapeutic use
  • Viral Load
  • Virus Replication/drug effects
Research groups
Citation (ISO format)
BEGUELIN, Charles et al. Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study. In: Clinical Infectious Diseases, 2017, vol. 64, n° 9, p. 1275–1278. doi: 10.1093/cid/cix125
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1058-4838
401views
0downloads

Technical informations

Creation06/11/2018 16:56:00
First validation06/11/2018 16:56:00
Update15/03/2023 15:16:52
Status update15/03/2023 15:16:52
Last indexation31/10/2024 12:17:09
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack